UK biotech Oxford BioDynamics has presented data showing that the company’s blood test can predict patient...
Up To Date
Latest News
Swiss biopharma company Urovant Sciences has launched its IPO on Nasdaq, seeking US$150m. The proceeds will go...
Danish Genmab and German Immatics Biotechnologies are collaborating to discover and develop next-generation...
Using only openly available genomic data, researchers in Barcelona have developed a new method to...
Norwegian diabetes expert Lifecare AS has gone public on the Oslo stock exchange. The sensor maker plans to...
Bioscience investment firm Abingworth has closed its latest fund at US$315m (€268m). The money will go to life...